Cargando…
Targeting 3D chromosomal architecture at the RANK loci to suppress myeloma-driven osteoclastogenesis
Bone disease represents a major cause of morbidity and mortality in Multiple Myeloma (MM); primarily driven by osteoclasts whose differentiation is dependent on expression of RANKL by MM cells. Notably, costimulation by ITAM containing receptors (i.e., FcγR) can also play a crucial role in osteoclas...
Autores principales: | Thümmler, Katja, Williams, Mark TS, Kitson, Susan, Sood, Shatakshi, Akbar, Moeed, Cole, John J, Hunter, Ewan, Soutar, Richard, Goodyear, Carl S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348127/ https://www.ncbi.nlm.nih.gov/pubmed/35936985 http://dx.doi.org/10.1080/2162402X.2022.2104070 |
Ejemplares similares
-
Notch signaling drives multiple myeloma induced osteoclastogenesis
por: Colombo, Michela, et al.
Publicado: (2014) -
Nanovibrational stimulation inhibits osteoclastogenesis and enhances osteogenesis in co-cultures
por: Kennedy, John W., et al.
Publicado: (2021) -
Inhibition of osteoclastogenesis by RNA interference targeting RANK
por: Ma, Ruofan, et al.
Publicado: (2012) -
Bone Marrow Stromal Cells Derived MCP-1 Reverses the Inhibitory Effects of Multiple Myeloma Cells on Osteoclastogenesis by Upregulating the RANK Expression
por: Liu, Zhiqiang, et al.
Publicado: (2013) -
Artesunate inhibits osteoclastogenesis through the miR-503/RANK axis
por: Huang, Ming-Zhi, et al.
Publicado: (2020)